28 October
2024
Assura plc
Proposed secondary listing on
the Johannesburg Stock Exchange
Assura plc ("Assura" or the
"Company"), the UK's leading diversified healthcare REIT, is
pleased to announce that it is in the process of applying for a
secondary inward listing on the Main Board of the Johannesburg
Stock Exchange (JSE) by way of an introduction.
Assura believes that admission to
trading of the shares on the JSE will be beneficial to the Company
and its stakeholders. The Board of Assura believes that the
secondary listing can be expected to contribute to liquidity in the
Company's shares through its increased profile in the South African
market.
The listing of Assura on the JSE is
expected to become effective later this year, subject to the
necessary regulatory approvals in South Africa. The Company will
not place or issue any new Assura shares in connection with its
application for a secondary listing on the JSE and will remain
listed on the Equity Shares (Commercial Companies) category (ESCC)
of the Official List in London.
HSBC is acting as Listing
Co-ordinator and Corporate Broker and Nedbank Corporate and
Investment Banking, a division of Nedbank Limited, as JSE
Sponsor.
Jonathan Murphy, CEO, said:
"We are excited to announce that we
are moving forward with an application for a secondary listing on
the Johannesburg Stock Exchange which we believe will contribute to
liquidity in our shares.
"As the UK's leading diversified
healthcare REIT, Assura offers an attractive proposition to South
African investors, who we look forward to welcoming onto our share
register. Our high quality assets offer long-term secured and
growing income, underpinned by the long-term structural demand for
healthcare services."
- Ends
-
For more information, please
contact:
|
Assura plc
|
Tel: 0161 515 2043
|
|
David Purcell, Investor Relations
Director
|
Email: Investor@assura.co.uk
|
|
FGS Global
Gordon Simpson
Grace Whelan
|
Tel: 0207 251
3801
Email: Assura@fgsglobal.com
|
|
HSBC Bank Plc
Chloe Ponsonby
Jonathan Surr
Louis Davies
|
Tel: 020
7991 8888
|
Notes to Editors
Assura plc is
the UK's leading diversified healthcare REIT. Assura
enables better health outcomes through its portfolio of more than
600 healthcare buildings, from which over six million patients are
served.
A UK REIT based
in Altrincham, Assura is a constituent of the FTSE 250 and the
EPRA* indices. As at 31 March 2024, Assura's portfolio was valued
at £2.7 billion and has a strong track record of growing
financial returns and dividends for shareholders.
At Assura, we BUILD for health,
having developed over 100 new healthcare buildings in our history,
and at the heart of our strategy sits The Bigger Picture; Healthy
Environment (E), Healthy Communities (S), Healthy Business
(G).
Further information is available
at www.assuraplc.com
*EPRA is a
registered trademark of the European Public Real Estate
Association
